Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Armin Mooranian, Nassim Zamani, Momir Mikov, Svetlana Goločorbin-Kon, Goran Stojanovic, Frank Arfuso & Hani Al-Salami. (2018) Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 741-747.
Read now
Read now
Sangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso & Hani Al-Salami. (2016) A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes. Drug Delivery 23:8, pages 2869-2880.
Read now
Read now
Vineet Kumar Rai, Nidhi Mishra, Ashish Kumar Agrawal, Sanyog Jain & Narayan Prasad Yadav. (2016) Novel drug delivery system: an immense hope for diabetics. Drug Delivery 23:7, pages 2371-2390.
Read now
Read now
Sangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso & Hani Al-Salami. (2016) The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1508-1519.
Read now
Read now
Armin Mooranian, Rebecca Negrulj, Sangeetha Mathavan, Jorge Martinez, Jessica Sciarretta, Nigel Chen-Tan, T. K. Mukkur, Momir Mikov, Mladena Lalic-Popovic, Maja Stojancevic, Svetlana Golocorbin-Kon & Hani Al-Salami. (2015) An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharmaceutical Development and Technology 20:6, pages 702-709.
Read now
Read now
Armin Mooranian, Rebecca Negrulj, Hesham S. Al-Sallami, Zhongxiang Fang, Momir Mikov, Svetlana Golocorbin-Kon, Marc Fakhoury, Frank Arfuso & Hani Al-Salami. (2015) Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. Journal of Microencapsulation 32:2, pages 151-156.
Read now
Read now
Xiaowei Zhang, Chong Zhang, Wei Zhang, Shu Meng, Danhua Liu, Ping Wang, Jing Guo, Jianxin Li, Yanmin Guan & Dan Yang. (2015) Feasibility of poly (ε-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation. Drug Development and Industrial Pharmacy 41:2, pages 342-352.
Read now
Read now
Armin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, Hesham S Al-Sallami, Zhongxiang Fang, Trilochan Mukkur, Momir Mikov, Svetlana Golocorbin-Kon, Marc Fakhoury, Frank Arfuso & Hani Al-Salami. (2014) Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Design, Development and Therapy 8, pages 1003-1012.
Read now
Read now
Articles from other publishers (7)
Armin Mooranian, Louise Carey, Corina Mihaela Ionescu, Daniel Walker, Melissa Jones, Susbin Raj Wagle, Bozica Kovacevic, Thomas Foster, Jacqueline Chester, Edan Johnston, Momir Mikov & Hani Al-Salami. (2021) The Effects of Accelerated Temperature-Controlled Stability Systems on the Release Profile of Primary Bile Acid-Based Delivery Microcapsules. Pharmaceutics 13:10, pages 1667.
Crossref
Crossref
Susbin Raj Wagle, Bozica Kovacevic, Corina Mihaela Ionescu, Daniel Walker, Melissa Jones, Louise Carey, Ryusuke Takechi, Momir Mikov, Armin Mooranian & Hani Al-Salami. (2021) Pharmacological and Biological Study of Microencapsulated Probucol-Secondary Bile Acid in a Diseased Mouse Model. Pharmaceutics 13:8, pages 1223.
Crossref
Crossref
Susbin Raj Wagle, Bozica Kovacevic, Daniel Walker, Corina Mihaela Ionescu, Melissa Jones, Goran Stojanovic, Sanja Kojic, Armin Mooranian & Hani Al-Salami. (2020) Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations. Pharmaceutics 12:8, pages 708.
Crossref
Crossref
Armin Mooranian, Nassim Zamani, Momir Mikov, Svetlana Goločorbin-Kon, Goran Stojanovic, Frank Arfuso, Bozica Kovacevic & Hani Al-Salami. (2020) A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. Saudi Pharmaceutical Journal 28:2, pages 165-171.
Crossref
Crossref
Armin Mooranian, Nassim Zamani, Momir Mikov, Svetlana Goločorbin-Kon, Goran Stojanovic, Frank Arfuso & Hani Al-Salami. (2018)
Eudragit
®
-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
. Therapeutic Delivery 9:11, pages 811-821.
Crossref
Crossref
Sangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso & Hani Al-Salami. (2018) Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile Acid. AAPS PharmSciTech 19:7, pages 3009-3018.
Crossref
Crossref
Armin Mooranian, Rebecca Negrulj, Sangeetha Mathavan, Jorge Martinez, Jessica Sciarretta, Nigel Chen-Tan, TK Mukkur, Momir Mikov, Mladena Lalic-Popovic, Maja Stojančević, Svetlana Golocorbin-Kon & Hani Al-Salami. (2014) Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics. Journal of Pharmaceutical Innovation 9:2, pages 150-157.
Crossref
Crossref